ArticleFrontiers in immunology2022

Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.

Franziska Blaeschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.